Novartis launches Gleevec action against Dr. Reddy’s

28-03-2014

Novartis launches Gleevec action against Dr. Reddy’s

Novartis has sued generic drugmaker Dr. Reddy’s Laboratories for infringing a patent related to its chronic myelogenous leukaemia (CML) drug Gleevec/Glivec (imatinib mesylate).


Gleevec, Glivec, Novartis, Dr. Reddy’s, ANDA

LSIPR